 |
|
 |
| |
| |
Articles |
| |
| |
FDG-PET/CT |
| |
 |
Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol. 2001 Mar;2:157-64. |
| |
|
Ell PJ. The contribution of PET/CT to improved patient management. Br J Radiol. 2006;79:32-6. |
| |
|
Kayani I, Groves AM. 18F-fluorodeoxyglucose PET/CT in cancer imaging. Clin Med. 2006;6:240-4 |
| |
|
Miller JC, Fischman AJ, Aquino SL, Blake MA, Thrall JH, Lee SI. FDG-PET CT for tumor imaging. J Am Coll Radiol. 2007 Apr;4(4):256-9 |
| |
|
Jadvar H, Henderson RW, Conti PS. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8 |
| |
|
Hillner B, Siegel B, Liu D, Shields A et al. Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) alone on expected management of patients with cancer: Initial results from the National Oncologic PET Registry. J Clin Oncol.2008;26:2155 - 61 |
| |
Rubidium-82 PET/CT |
| |
|
Sampson U K, Dorbola S, Limaye A, Kwong R, Di Carli. Diagnostic accuracy of Rubidium-82 myocardial perfusion imaging with hybrid Positron Emission Tomography/Computed Tomography in the detection of Coronary Artery Disease . J Am Coll Cardiol 2007;49: 1052-58 |
| |
|
Knesaurek K, Machac J, Krynyckyi B, Almeida O. Comparison of 2-Dimensional and 3-Dimensional Rubidium-82 myocardial perfusion PET imaging. J Nuc Med 2003;44:1350-56 |
| |
|
Yoshinaga K, Chow B, Williams K, Li Chen et al. What is the prognostic value of myocardial perfusion imaging using Rubidium-82 PET. J Am Coll Cardiol 2006;48:1029-39 |
| |
|
Groves A, Kayani I, Dickson J, Endozo R et al. Cardiac Rubidium-82 PET/CT: initial European experience. Eur J Nucl Med Mol Imaging;34:1965-72 |
| |
|
Machac J, Bacharach S, Bateman T, Bax J et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006;13:e121-51 |
| |
|
Di Carli, Dorbala S, Meserve J, El Fakhri et al. Clinical myocardial perfusion PET/CT. |
| |
Gallium-68 PET/CT |
| |
|
Ambrosini V, Tomassetti P, Castellucci P, Campana et al. Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. Eur J Nucl Med Mol Imaging. 2008;35:1431-8. |
| |
|
Al-Nahhas, Win Z, Szyszko T, Singh A et al. What can gallium-68 PET ad to receptor and molecular imaging. Eur J Nucl Med Mol Imaging. 2007;34:1897-901 |
| |
|
Pettinato C, Sarnelli A, Donna M, Civollani S et al. Gallium-68 DOTANOC:biodistribution and dosimetry in patients affected by neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2008;51: 72-79. |
| |
|
Al-Nahhas A, Win Z, Szyszko T, Singh A, Nanni C, Fanti S, Rubello D. Gallium-68 PET: a new frontier in receptor cancer imaging. Anticancer Res. 2007;27:4087-94. |
| |
|
Khan S, Lloyd C, Szyszko T, Win Z, Rubello D, Al-Nahhas A. PET imaging in endocrine tumours. Minerva Endocrinol. 2008;33:41-52 |
| |
|
Ambrosini V, Tomassetti P, Castellucci P, Campana D, Montini G, Rubello D et al. Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. Eur J Nucl Med Mol Imaging. 2008 Aug;35:1431-8 |
|
| |
|
|
 |
